![Tina Albertson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tina Albertson
Teknisk/Vetenskaplig/F&U Direktör på
CARIBOU BIOSCIENCES, INC.
Förmögenhet: 100 044 $ per 2026-07-31
Profil
Tina Albertson is currently Chief Medical Officer at Caribou Biosciences, Inc. since 2024.
Formerly, Dr. Albertson was Chief Medical Officer & Head-Development at Lyell Immunopharma, Inc. from 2020 to 2023, Vice President-Global Drug Development at Juno Therapeutics, Inc. from 2015 to 2020, and Medical Director at Seagen, Inc. from 2010 to 2015.
Education includes a doctorate from Stanford University, a doctorate from the University of Washington, and an undergraduate degree from the University of Oregon.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-02-24 | 68 523 ( 0,07 % ) | 100 044 $ | 2026-07-31 |
Aktiva positioner av Tina Albertson
| Företag | Position | Start |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-08-12 |
Tidigare kända positioner av Tina Albertson
| Företag | Position | Slut |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-11-01 |
| JUNO THERAPEUTICS INC | Företagsledare/Principal | 2020-04-01 |
| SEAGEN INC. | Teknisk/Vetenskaplig/F&U Direktör | 2015-01-01 |
Tina Albertsons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
67
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
